Inogen Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
13,521.00
56,836.00
82,899.00
113,884.00
173,944.00
240,349
Total Accounts Receivable
10,318.00
21,478.00
22,030.00
32,261.00
32,757.00
39,696
Inventories
4,248.00
7,616.00
8,648.00
14,343.00
18,842.00
27,071
Other Current Assets
4,743.00
6,098.00
870.00
659.00
2,584.00
7,108
Total Current Assets
32,830.00
92,028.00
114,447.00
161,147.00
228,127.00
314,224
Net Property, Plant & Equipment
29,722.00
31,927.00
30,680.00
25,199.00
20,103.00
22,341
Intangible Assets
215.00
270.00
229.00
241.00
7,080.00
6,012
Other Assets
1,765.00
612.00
494.00
808.00
1,126.00
3,191
Total Assets
82,397.00
140,085.00
161,314.00
214,049.00
275,072.00
375,898
ST Debt & Current Portion LT Debt
5,258.00
299.00
315.00
-
-
Accounts Payable
9,219.00
11,273.00
10,996.00
10,028.00
16,793.00
Income Tax Payable
-
-
11.00
-
345.00
Other Current Liabilities
5,194.00
7,163.00
10,691.00
12,817.00
16,748.00
Total Current Liabilities
19,671.00
18,735.00
22,013.00
22,845.00
33,886.00
Long-Term Debt
5,391.00
315.00
-
-
-
Provision for Risks & Charges
-
334.00
747.00
1,792.00
3,666.00
Deferred Taxes
17,865.00
15,248.00
15,464.00
26,654.00
18,288.00
Other Liabilities
1,036.00
2,551.00
4,536.00
7,324.00
10,131.00
Total Liabilities
26,098.00
21,935.00
27,296.00
31,961.00
48,031.00
Common Equity (Total)
62,619.00
118,150.00
134,018.00
182,088.00
227,041.00
Total Shareholders' Equity
56,299.00
118,150.00
134,018.00
182,088.00
227,041.00
Total Equity
56,299.00
118,150.00
134,018.00
182,088.00
227,041.00
Liabilities & Shareholders' Equity
82,397.00
140,085.00
161,314.00
214,049.00
275,072.00
Preferred Stock (Carrying Value)
118,918.00
-
-
-
-

About Inogen

View Profile
Address
326 Bollay Drive
Goleta California 93117
United States
Employees -
Website http://www.inogen.net
Updated 07/08/2019
Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home.